Neisseria gonorrhoeae¶
Neisseria gonorrhoeae data are sourced from Pathogenwatch, which calls AMR and lineage genotypes (MLST, NG-MAST) from genomes assembled from public data. The prevalence estimates shown are calculated using genome collections derived from non-targeted sampling frames (i.e. surveillance and burden studies, as opposed to AMR focused studies or outbreak investigations). These include EuroGASP 2013 & 2018, and several national surveillance studies. Last update: 5 August 2025.
Definiciones variables¶
Genotypes: sequence types from the 7-locus MLST scheme for Neisseria, or 2-locus N. gonorrhoeae multi-antigen sequence typing (NG-MAST) scheme, both hosted by PubMLST.
AMR determinants are identified by Pathogenwatch using an inhouse dictionary developed and maintained in consultation with an expert advisory group, described here.
AMR determinants within genotypes - This plot shows combinations of determinants that result in clinical resistance to Azithromycin or Ceftriaxone, as defined in Figure 3 of Sánchez-Busó et al (2021).
Susceptible a los medicamentos I/II - No se encontraron determinantes para la Azitromicina, Ceftriaxona, Cefixime (categoría I) o Benzilpenicillina, Ciprofloxacina, Espectinomicina (categoría I).
Abbreviations¶
MDR: multirresistente (resistente a uno de Azitromicina / Ceftriaxona / Cefixime [categoría I representantes], más dos o más de Benzylpenicillin / Ciprofloxacin / Espectinomicina [Representantes de categoría II])
XDR: ampliamente resistente a medicamentos (resistente a dos de Azitromicina / Ceftriaxona / Cefixime [categoría I representantes], más tres de Benzylpenicillin / Ciprofloxacin / Espectinomicina [categoría II representantes])
Nota
These definitions are based on those defined in the European CDC Response Plan, modified to use the specific representatives of category I and II antibiotic classes that are available in the dashboard.
Data source¶
The data are collated from studies with the following PubMed IDs:
Study accession |
PMID |
|---|---|
PRJEB58139 |
38614111 |
PRJEB4024 |
32013864 |
PRJEB4024 |
31358980 |
PRJNA266539 |
25378573 |
PRJNA298332 |
26935729 |
PRJEB7904 |
27638945 |
PRJNA348107 |
28510723 |
PRJEB23008 |
29523496 |
PRJEB14168 |
28348871 |
PRJNA209340, PRJNA209376, PRJNA209345, PRJNA209319 PRJNA209352, PRJNA209333, PRJNA209347, PRJNA209316 PRJNA209466, PRJNA209373, PRJNA209465, PRJNA209351 PRJNA209342, PRJNA209343, PRJNA209320, PRJNA209470 |
25780762 |
PRJEB17738 |
29247013 |
PRJEB10104 |
29701830 |
PRJDB6504,PRJDB6496 |
30063202 |
PRJEB34425 |
32068837 |
PRJEB10016 |
32829411 |
PRJNA392203 |
29367612 |
PRJNA473385 |
29882175 |
PRJEB19989 |
31978353 |
PRJEB9227 |
29776807 |
PRJNA394216 |
29182725 |
PRJNA317462 |
30788502 |
PRJEB14933 |
26601852 |
PRJEB32435 |
33200978 |
PRJNA315363 |
27427203 |
PRJEB34425 |
32068837 |
PRJNA317462, PRJNA329501 |
32071056 |
PRJEB32435 |
32213251 |
PRJNA520805 |
31488838 |
PRJEB34068 |
35659907 |
PRJEB2999 |
24462211 |
PRJEB32435 |
32213251 |
PRJEB49317 |
35467402 |
PRJEB47922 |
35095823 |
PRJEB50649 |
37216766 |
PRJEB36607 |
32785692 |
PRJEB36608 |
30820563 |
PRJEB40983 |
33739419 |
PRJEB41007 |
34424175 |
PRJNA315363 |
27427203 |
PRJNA317462 |
30788502, 33005903, 33993166, 37171855 |
PRJNA329501 |
33005903 |
PRJNA278367 |
26358608 |
PRJNA481622 |
32977759 |
PRJNA575338 |
32868325 |
PRJNA594714 |
32571818 |
PRJNA664319 |
33760080 |
PRJNA681740 |
34280016 |
PRJNA684048 |
34683991 |
PRJNA738299 |
34755593 |
PRJNA522696 |
10.1136/sextrans-2019-054025 |
PRJNA776899 |
36735316 |
PRJNA785548 |
34978884 |